Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNausea is the most commonly reported side effect of Wegovy (semaglutide), affecting the majority of people at some point during treatment — most often in the first few weeks or after a dose increase. For most people, it is mild to moderate and settles on its own. Understanding why nausea on Wegovy happens, and knowing which steps genuinely help, makes it far easier to decide whether to push through or pick up the phone. Wegovy is a prescription-only medicine; a prescriber assesses suitability and discusses side effects with you before treatment begins. Learn more about how Wegovy works as background to everything below.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first decision most people face is a simple but anxious one: is what I am feeling normal, or a warning sign? The NHS semaglutide medicines page lists nausea as one of the most common reactions, alongside vomiting, diarrhoea, constipation and indigestion. It typically arrives within hours of an injection, often peaks on day two or three, and then softens over the following days. After a dose increase the cycle can restart briefly. That pattern, uncomfortable as it is, is not dangerous.
What warrants faster action is a different kind of stomach pain: severe, continuous pain that drills into your back, possibly accompanied by vomiting that will not stop. That picture can indicate acute pancreatitis, an infrequent but serious reaction. In January 2026 the MHRA issued a Drug Safety Update specifically highlighting pancreatitis as a risk with GLP-1 medicines, the guidance is clear that this symptom needs urgent medical help, not watchful waiting. If that is what you are experiencing, stop reading and call 999 or go to A&E.
For the everyday queasy feeling that trails a fresh injection, the decision framework is different. It is about comfort, persistence and whether you can keep fluids down. Most people find practical ways to get through the early weeks without stopping treatment altogether.
Knowing the mechanism behind wegovy nausea does more than satisfy curiosity; it shapes what actually helps. Semaglutide activates GLP-1 receptors in the gut and the brain. One effect is slower gastric emptying: food and liquid sit in the stomach longer than usual. Another is a direct signal to the brain's nausea centres. Put those together and the result, especially early on, is a sensation of fullness that tips into queasiness if you eat too quickly, too much, or the wrong things.
That is why large meals are the most reliable trigger. A big plate of fatty or spicy food shortly after an injection is almost asking for trouble in the early weeks. Smaller portions, eaten slowly, with time between courses, give the slower-emptying stomach less to complain about. The same logic applies to lying down immediately after eating. A fuller explanation of the biology is worth reading if the mechanism interests you.
The dose-titration schedule exists partly for this reason. Starting at a lower dose gives the gut a chance to adapt before the dose climbs. Rushing the schedule, or missing injections and then resuming at the same dose, can bring nausea back with more force. Your prescriber decides the pace; the patient information leaflet sets out the specifics.
There is no single trick that works for everyone, but several adjustments reliably help enough people that they are worth trying before concluding treatment is intolerable. A detailed breakdown of the approaches covers these in depth, but the headline points are these: eat smaller portions and stop before you feel full; choose bland, lower-fat foods in the first few days after each injection; stay upright for at least an hour after eating; drink water steadily throughout the day rather than in large amounts at once.
Timing the injection itself can help too. Some people find that injecting on a Friday evening means the worst of any nausea falls over a weekend, when they can rest rather than push through a working day. If payday lands on a Monday and that is when your repeat order arrives, injecting Sunday evening is one small adjustment that can make a real difference to the week ahead.
If nausea and diarrhoea are occurring together, that combination needs careful attention to hydration. Losing fluids from both ends simultaneously can lead to dehydration surprisingly quickly. Sip water consistently and contact a healthcare professional if you cannot keep fluids down for more than 24 hours, or if you feel faint or very dizzy.
Three scenarios call for medical contact rather than self-management. First, the severe radiating stomach pain described above. Second, signs of dehydration that are not resolving, dark urine, feeling lightheaded when standing, confusion, inability to keep even small sips of water down. Third, nausea that has not eased at all after several weeks at the same dose, or that is severe enough to stop you eating or drinking adequately. A prescriber may consider whether the dose needs to stay where it is for longer, or whether another approach is more appropriate.
It is also worth knowing that some people experience semaglutide nausea differently depending on other medicines they take, their diet, and individual gut sensitivity. None of these variables can be fully predicted in advance, which is part of why ongoing clinical oversight matters rather than just an initial sign-off. The full side-effect picture for Wegovy covers reactions beyond the GI system, including the rare hair-thinning that some people notice, and whether that is permanent is a question our prescribers are asked regularly.
If you have concerns at any point during treatment, our prescribers are available seven days a week. Suitability, side effects and how to manage them are all discussed as part of the free consultation. You can start that conversation here with no obligation, or contact our team directly if you are already on treatment and need support.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.